Citius Pharmaceuticals (CTXR) Financials: Revenue & Earnings

CTXR price $0.53 +0.03 +6.64%

Ticker
CTXR
Price
$0.53
Change
+0.03 +6.64%
Market cap ?
$14.68M
P/E ?
-0.19
Forward P/E ?
2.43
Dividend yield ?
0.00%
Beta ?
1.00
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
0000000000

Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline…

Fair value

CTXR fair value $8.51. Price $0.53. Price is 94% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare CTXR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-12-22—-0.41—2.94M
2026-08-14-0.34-0.361.49M5.46M
2026-05-15-0.950.391.67M18.79M
2026-02-13-0.380.433.94M18.01M
2025-12-26-0.01-0.433.94M5.76M
2025-08-12-0.80-0.51—1.92M
2025-05-14-1.27-1.08—5.33M
2025-02-14-1.30-1.25—2.67M
2025-01-03-1.50-0.04—7.06M
2024-08-12-1.50-1.25—15.43M
2024-05-14-1.25-1.38—14.81M
2024-02-14-1.503.25—21.30M
2024-01-02-0.08-0.02——
2023-08-14-1.50-0.06——
2023-05-12-1.75-1.00——
2023-02-10-0.50———
2022-12-22-1.25-0.04——
2022-08-11-0.06-0.05——
2022-05-12-0.05-0.07——
2022-02-10-0.06-1.50—19.16M
2021-12-15-0.75-0.75—19.15M
2021-08-12-0.05-1.25——
2021-05-13-0.04-2.00——
2021-02-11-0.150.16—9.39M
2020-12-16-0.07-0.10——
2020-08-14-0.11-0.10——
2020-05-14-0.13-0.10——
2020-02-13-0.15-0.14——
2019-12-16-0.16-0.14——
2019-08-14-0.20-1.50——
2019-05-15-0.20-0.20——
2019-02-14-0.22-0.21——
2018-12-11-0.27———
2018-08-14-0.19-0.32——
2018-05-11-0.44———
2018-03-20-0.38———
2017-12-13-0.56———
2017-08-14-0.48———
2017-05-15-0.55———
2017-02-14-0.44———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2025-08-08Mazur Leonard LBuy125.49K$28.753.61M
2025-08-08Mazur Leonard LBuy89.39K$19.251.72M
2025-08-08Mazur Leonard LSell125.49K$28.753.61M
2025-08-08Mazur Leonard LSell89.39K$19.251.72M
2025-08-08HOLUBIAK MYRON ZBuy31.37K$28.75901.97K
2025-08-08HOLUBIAK MYRON ZBuy22.34K$19.25430.12K
2025-08-08HOLUBIAK MYRON ZSell22.34K$19.25430.12K
2025-08-08HOLUBIAK MYRON ZSell31.37K$28.75901.97K
2024-11-07Webb CarolBuy125.00K$0.3847.50K
2024-11-07Smith Robert JosephBuy125.00K$0.3847.50K
2024-11-07Bartushak JaimeBuy350.00K$0.38133.00K
2024-11-07Mazur Leonard LBuy600.00K$0.38228.00K
2024-11-07Czuczman MyronBuy300.00K$0.38114.00K
2024-11-07Dutia Suren GBuy125.00K$0.3847.50K
2024-11-07MCGRATH DENNIS MBuy125.00K$0.3847.50K
2024-11-07HOLUBIAK MYRON ZBuy350.00K$0.38133.00K
2024-11-07HOLUBIAK MYRON ZBuy75.00K$0.3828.50K
2024-11-07Holuka Eugene MyronBuy125.00K$0.3847.50K
2024-09-25HOLUBIAK MYRON ZBuy558.60K$0.77430.12K
2024-09-25HOLUBIAK MYRON ZSell558.60K$0.77430.12K
2024-09-25Mazur Leonard LBuy2.23M$0.771.72M
2024-09-25Mazur Leonard LSell2.23M$0.771.72M
2024-08-14HOLUBIAK MYRON ZBuy784.31K$1.15901.96K
2024-08-14HOLUBIAK MYRON ZSell784.31K$1.15901.96K
2024-08-14Mazur Leonard LBuy3.14M$1.153.61M
2024-08-14Mazur Leonard LSell3.14M$1.153.61M
2024-04-03Mazur Leonard LBuy1.17M$1.421.65M
2024-04-03Mazur Leonard LSell1.17M$1.421.65M
2024-04-03HOLUBIAK MYRON ZBuy129.45K$1.42183.82K
2024-04-03HOLUBIAK MYRON ZSell129.45K$1.42183.82K
2024-03-14Smith Robert JosephBuy75.00K$0.6951.75K
2024-03-13Holuka Eugene MyronBuy2.42K$0.0136
2024-03-13Holuka Eugene MyronSell48$0.7536
2024-03-13Holuka Eugene MyronSell2.42K$0.0136
2024-03-12Smith Robert JosephOther0——
2024-03-04Webb CarolBuy12.07K$0.01181
2024-03-04Webb CarolSell236$0.77181
2024-03-04Webb CarolSell12.07K$0.01181
2023-10-10Webb CarolBuy75.00K$0.7052.50K
2023-10-10Czuczman MyronBuy300.00K$0.70210.00K
2023-10-10HOLUBIAK MYRON ZBuy400.00K$0.70280.00K
2023-10-10Holuka Eugene MyronBuy75.00K$0.7052.50K
2023-10-10MCGRATH DENNIS MBuy75.00K$0.7052.50K
2023-10-10Bartushak JaimeBuy300.00K$0.70210.00K
2023-10-10Dutia Suren GBuy75.00K$0.7052.50K
2023-10-10Mazur Leonard LBuy550.00K$0.70385.00K
2023-02-07MCGRATH DENNIS MBuy75.00K$1.42106.50K
2023-02-07MCGRATH DENNIS MOther0——
2022-10-04Mazur Leonard LOther0——
2022-10-04Kane WilliamBuy75.00K——
2022-10-04Dutia Suren GBuy75.00K——
2022-10-04HOLUBIAK MYRON ZBuy400.00K——
2022-10-04Mazur Leonard LBuy550.00K——
2022-10-04Bartushak JaimeBuy300.00K——
2022-10-04SAFIR HOWARDBuy75.00K——
2022-10-04Holuka Eugene MyronBuy75.00K——
2022-10-04Webb CarolBuy75.00K——
2022-10-04Czuczman MyronBuy300.00K——
2021-10-11HOLUBIAK MYRON ZBuy650.00K$2.041.33M
2021-10-11HOLUBIAK MYRON ZBuy15.00K$2.0430.60K
2021-10-11Mazur Leonard LBuy650.00K$2.041.33M
2021-10-11Webb CarolBuy75.00K$2.04153.00K
2021-10-11Bartushak JaimeBuy300.00K$2.04612.00K
2021-10-11SAFIR HOWARDBuy75.00K$2.04153.00K
2021-10-11Holuka Eugene MyronBuy75.00K$2.04153.00K
2021-10-11Dutia Suren GBuy75.00K$2.04153.00K
2021-10-11Czuczman MyronBuy300.00K$2.04612.00K
2021-10-11Kane WilliamBuy75.00K$2.04153.00K
2021-07-22Kane WilliamBuy15.00K$2.0030.00K
2021-07-22Dutia Suren GBuy15.00K$2.0030.00K
2021-07-22HOLUBIAK MYRON ZBuy300.00K$2.00600.00K
2021-07-22HOLUBIAK MYRON ZBuy10.00K$2.0020.00K
2021-07-22Mazur Leonard LBuy300.00K$2.00600.00K
2021-07-22Bartushak JaimeBuy100.00K$2.00200.00K
2021-07-22SAFIR HOWARDBuy15.00K$2.0030.00K
2021-07-22Holuka Eugene MyronBuy15.00K$2.0030.00K
2021-07-22Webb CarolBuy15.00K$2.0030.00K
2021-02-16Kane WilliamBuy25.00K$1.6942.25K
2021-02-16Dutia Suren GBuy25.00K$1.6942.25K
2021-02-16SAFIR HOWARDBuy25.00K$1.6942.25K
2021-02-16Holuka Eugene MyronBuy25.00K$1.6942.25K
2021-02-16Webb CarolBuy25.00K$1.6942.25K
2020-10-06Kane WilliamBuy35.00K$1.0135.35K
2020-10-06HOLUBIAK MYRON ZBuy200.00K$1.01202.00K
2020-10-06Dutia Suren GBuy35.00K$1.0135.35K
2020-10-06Mazur Leonard LBuy200.00K$1.01202.00K
2020-10-06Bartushak JaimeBuy125.00K$1.01126.25K
2020-10-06SAFIR HOWARDBuy35.00K$1.0135.35K
2020-10-06Holuka Eugene MyronBuy35.00K$1.0135.35K
2020-10-06Webb CarolBuy35.00K$1.0135.35K
2020-07-14Czuczman MyronBuy500.00K$1.19595.00K
2020-07-14Czuczman MyronOther0——
2020-07-07Webb CarolBuy25.00K$1.3934.75K
2020-07-07Holuka Eugene MyronBuy25.00K$1.3934.75K
2020-07-07Kane WilliamBuy25.00K$1.3934.75K
2020-07-07Dutia Suren GBuy25.00K$1.3934.75K
2020-07-07SAFIR HOWARDBuy25.00K$1.3934.75K
2019-10-08Webb CarolBuy25.00K$0.6716.75K
2019-10-08SAFIR HOWARDBuy25.00K$0.6716.75K
2019-10-08Mazur Leonard LBuy175.00K$0.67117.25K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 43, holders +3 vs prior quarter. Ownership 5.20%.

HolderSharesChangeChange %Value
GEODE CAPITAL MANAGEMENT, LLC215.54K-30.62K-12.44%130.30K
VANGUARD CAPITAL MANAGEMENT LLC197.36K29.63K+17.66%119.41K
MILLER FINANCIAL SERVICES LLC130.00K116.00K+828.57%78.58K
CITADEL ADVISORS LLC124.91K95.81K+329.24%75.51K
JANE STREET GROUP, LLC122.84K100.31K+445.38%74.25K
VANGUARD FIDUCIARY TRUST CO77.75K00.00%47.04K
BLACKROCK, INC.69.85K-1-0.00%42.22K
NORTHERN TRUST CORP62.74K18.77K+42.68%37.93K
XTX TOPCO LTD59.20K37.90K+177.99%35.79K
ASSET ADVISORY GROUP, INC.59.01K00.00%35.67K
BOSTONPREMIER WEALTH LLC28.00K28.00KNew16.93K
UBS GROUP AG26.34K-28.69K-52.14%15.93K
LPL FINANCIAL LLC25.45K400+1.60%15.38K
STATE STREET CORP23.27K00.00%14.07K
VIRTU FINANCIAL LLC20.84K20.84KNew13.00K
ARKADIOS WEALTH ADVISORS20.00K00.00%12.09K
TWO SIGMA INVESTMENTS, LP17.49K4.36K+33.16%10.57K
SANCTUARY ADVISORS, LLC11.81K11.81KNew7.14K
SUSQUEHANNA INTERNATIONAL GROUP, LLP11.79K11.79KNew7.13K
R SQUARED LTD11.03K11.03KNew6.67K
TWO SIGMA SECURITIES, LLC10.01K10.01KNew6.05K
SBI SECURITIES CO., LTD.9.52K3.00K+46.02%5.75K
CHELSEA COUNSEL CO4.63K00.00%2.80K
QUENT CAPITAL, LLC4.23K-33-0.77%2.56K
IFP ADVISORS, INC4.18K-2.90K-40.94%2.53K

Earnings and financials

Citius Pharmaceuticals, Inc. (CTXR) trades at $0.53, with a market cap of $14.68M and a trailing P/E of -0.19. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
0000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Citius Pharmaceuticals (CTXR) Financials: Revenue & Earnings

CTXR$0.53+0.03 +6.64%

$14.68M

Market Cap

-0.19

P/E

2.43

Forward P/E

—

Score

Price History